Related by context. All words. (Click for frequent words.) 73 Health Initiative WHI 58 ALLHAT 57 observational study 56 plus progestin 56 Wactawski Wende 56 AIM HIGH 56 randomized clinical 56 postmenopausal women 55 Memory Study WHIMS 55 meta analysis 55 menopausal hormone therapy 55 Prostate Cancer Prevention 55 observational studies 54 Digital Mammographic Imaging 54 hormone therapy 54 PLCO 54 postmenopausal hormone therapy 54 ONTARGET 54 estrogen therapy 53 randomized controlled trials 53 SCD HeFT 53 estrogen progestin 53 Screening Trial DMIST 53 folate supplementation 52 Framingham Offspring Study 52 substudy 52 hormone therapy estrogen 52 PLCO trial 52 randomized trials 52 RE LY 52 DMIST 52 BARI 2D 52 letrozole 52 estrogen progestin combination 52 CATIE 52 meta analyzes 51 Intervention Trial GAIT 51 Dietary Modification Trial 51 APPROVe 51 estrogen progestin therapy 51 randomized clinical trials 51 dutasteride 50 MADIT CRT 50 HIVNET 50 ELCAP 50 Prostate Lung Colorectal 50 CARE HF 50 randomized controlled trial 50 BCIRG 50 MADIT II 50 hormone replacement 50 ACCORD 50 bisphosphonate 50 ACUITY trial 50 tamoxifen therapy 50 HF ACTION 50 heartwire 50 HeFT 50 selenium supplementation 49 pre menopausal 49 MERLIN TIMI 49 WHIMS 49 prospective cohort 49 Health Initiative Observational 49 randomized 49 VADT 49 post menopausal 49 HRT 49 Swedish Mammography Cohort 49 HYVET 49 Wyeth Prempro 49 beta carotene supplementation 49 postmenopausal hormones 49 DSMB 49 Clinical Antipsychotic Trials 49 HPTN 49 RE LY ® 49 Prempro 49 postmenopausal 49 SWOG 48 progestin 48 lipid lowering therapy 48 CARDIA study 48 NEJM 48 raloxifene 48 folic acid supplementation 48 exemestane 48 iPrEx 48 menopausal women 48 oral contraceptives 48 anastrozole 48 statin 48 SPARCL 48 randomized controlled clinical trials 48 Interphone study 48 dietary questionnaires 48 conjugated equine estrogens 48 EVEREST II 48 HOPE TOO 48 rosiglitazone 48 conjugated equine estrogen 48 subgroup analyzes 48 tamoxifen 48 RE LY trial 48 statins 48 calcium supplementation 48 beta carotene supplements 47 Celecoxib APC trial 47 Prempro pills 47 dabigatran 47 rofecoxib 47 vitamin D supplementation 47 Femara 47 alendronate 47 NCCAM 47 TRITON TIMI 47 ATACAND 47 ENESTnd 47 Adenoma Prevention 47 LibiGel Phase III 47 rivaroxaban 47 ExTRACT TIMI 47 PSA screening 47 ibandronate 47 unblinded 47 PCPT 47 Ushercell 47 screening mammography 47 ACRIN 47 progestin pills 47 multicenter study 47 estrogen progestin pills 47 randomized controlled clinical 47 beta blocker therapy 47 subanalysis 47 NCI 47 SSRI 47 randomized controlled 47 clinical trial 47 Intervention Effectiveness 47 telmisartan 47 placebo controlled clinical 47 HORIZONS AMI 47 calcium supplements 47 longitudinal study 47 Ovarian Cancer Screening 47 mammographic density 46 SWiTCH 46 CAPRISA 46 ezetimibe simvastatin 46 Atherosclerosis Risk 46 DMPA 46 CHAMPION PCI 46 Val HeFT 46 MADIT 46 ACCOMPLISH 46 dose aspirin 46 placebo controlled 46 INTERHEART study 46 SPIRIT IV 46 hormone therapy HT 46 homocysteine levels 46 antioxidant supplements 46 Multicenter Automatic Defibrillator Implantation 46 folic acid vitamin B6 46 Aggressive Reduction 46 USPSTF 46 lipid lowering drugs 46 menopausal symptoms 46 epidemiological studies 46 APEX AMI trial 46 premenopausal 46 trials RCTs 46 Proellex TM 46 prospective randomized controlled 46 prospective observational cohort 46 National Heart Lung 46 cardiovascular mortality 46 premenopausal women 46 celecoxib 46 placebo controlled studies 46 Intervention Effectiveness CATIE 46 NSABP 46 PRADAXA 46 PREVENT IV 46 nesiritide 45 Nissen meta analysis 45 NICE SUGAR 45 PROactive 45 placebo controlled trials 45 homocysteine lowering 45 PARTNER Trial 45 NATRECOR R 45 Carotid Revascularization Endarterectomy vs. 45 AREDS 45 menopause hormones 45 Multicenter AIDS 45 nonfatal MI 45 NHANES 45 eptifibatide 45 rosuvastatin 45 PROactive study 45 ACCORD Lipid 45 Kaplan Meier analysis 45 statin therapy 45 EchoCRT 45 NHLBI 45 rosiglitazone Avandia 45 Multi Ethnic Study 45 multicenter 45 retrospective cohort study 45 Cohort Study MACS 45 tesmilifene 45 HORIZONS AMI trial 45 CURRENT OASIS 7 45 DAPT 45 fenretinide 45 lipid lowering medications 45 STICH trial 45 Glucosamine Chondroitin Arthritis 45 Trial PCPT 45 estrogen 45 TAXUS VI 45 ACTIVE W 45 ENDEAVOR clinical 45 RCTs 45 Ornish 45 tibolone 45 soy isoflavones 45 NO# [002] 45 subclinical hypothyroidism 45 candesartan 45 MIST II 45 Randomized Evaluation 45 SPIRIT III 45 nonrandomized 45 DASH diet 45 AVOREN 45 Cholesterol Levels SPARCL 45 ASTEROID 45 prospective nonrandomized 45 adjuvant hormonal therapy 45 ICD implants 45 metformin 45 ENDEAVOR IV 45 TAXUS IV 45 spontaneous preterm birth 45 testosterone supplementation 45 MEND CABG 44 SSRI antidepressants 44 double blinded randomized 44 Aromasin 44 ToGA 44 randomized placebo controlled 44 oral contraception 44 ENDEAVOR III 44 vitamin E 44 progestogen 44 Netherlands Cohort Study 44 multicenter clinical 44 myocardial infarctions 44 Hormone Therapy 44 rosuvastatin Crestor 44 asymptomatic carotid stenosis 44 phase IIIb 44 therapy HRT 44 valproate 44 WHEL 44 androgen suppression 44 folate intake 44 combination estrogen progestin 44 oral bisphosphonate 44 warfarin 44 selenium supplements 44 QMed 44 BRIM2 44 Dialysis Outcomes 44 bazedoxifene conjugated estrogens 44 Premarin 44 prospective randomized 44 oral bisphosphonates 44 retrospective observational study 44 Hormone Replacement Therapy 44 NSABP B 44 HAART 44 Ortho Evra patch 44 spontaneous preterm delivery 44 PRoFESS 44 JoAnn Manson 44 sevelamer 44 Fablyn 44 hormone pills 44 Cochrane reviewers 44 SAMe 44 epidemiologic studies 44 randomized Phase III 44 pioglitazone 44 CAPRIE 44 CYPHER R Sirolimus eluting 44 NEVO RES 44 atazanavir 44 unblinding 44 coxib 44 risedronate 44 periprocedural MI 44 adjuvant chemotherapy 44 IMPROVE IT 44 Aggressive Drug Evaluation 44 multicenter placebo controlled 44 multicentre randomized 44 confirmatory clinical 44 valsartan 44 Zometa 44 study 44 TDF FTC 44 ASCOT LLA 44 DCCT 44 unfractionated heparin 44 PremPro 44 Wisconsin Sleep Cohort 44 everolimus eluting stent 44 Glucosamine chondroitin Arthritis 43 menopause 43 colorectal adenomas 43 afatinib 43 statin drugs 43 ticagrelor 43 Slone Epidemiology Center 43 undergone hysterectomies 43 vitamin D supplements 43 Atherosclerosis MESA 43 aldosterone antagonists 43 Raloxifene Evaluation MORE 43 darunavir ritonavir 43 Stacy Tessler Lindau 43 Leitzmann 43 aprotinin 43 ERSPC 43 Screening Trial 43 adjuvant radiotherapy 43 prospective multicenter 43 phase IIb clinical 43 International Verapamil SR 43 bivalirudin 43 teriparatide 43 STRIDE PD 43 observational cohort 43 generalizability 43 Phase Ib clinical 43 bisphosphonates 43 multicenter trials 43 Lung Screening 43 LMWH 43 RESOLUTE clinical 43 Osteoporotic Fractures 43 folic acid supplements 43 ABSORB trial 43 conjugated estrogen 43 MADIT CRT trial 43 eprotirome 43 BYSTOLIC 43 Women Ischemia Syndrome 43 PROactive Study 43 NATRECOR ® 43 multicenter randomized controlled 43 iPrEx study 43 pregabalin 43 Braunwald 43 Gynecologic Oncology Group 43 Clinical Outcomes Utilizing Revascularization 43 Buijsse 43 paroxetine 43 DHA supplementation 43 abnormal mammograms 43 mg d 43 CALGB 43 ICON7 43 thiazide diuretics 43 Cochrane Systematic Review 43 prospective longitudinal 43 viral kinetic 43 INTERPHONE 43 dietary calcium intake 43 pioglitazone Actos 43 oophorectomy 43 Antihypertensive 43 virologic failure 43 prospective multicentre 43 cerebrovascular events 43 ARIXTRA 43 ClinicalTrials.gov 43 AVERROES 43 cangrelor 43 CARDIA 43 premenopausal breast cancer 43 ECASS 43 AVANDIA 43 solifenacin 43 TAXUS Stent 43 estrogen pills 43 COX 2 43 mammography screening 43 amiodarone 43 Mofenson 43 prelicensure 43 REALITY Trial 43 Prospective Investigation 43 GISSI 43 newer antipsychotics 43 HbA1c levels 43 multicenter prospective 43 CALGB # [002] 43 PHPT 43 GVAX 43 isoflavone supplement 43 nonvertebral fractures 43 hydroxyurea 43 dose oral contraceptives 43 bisphosphonate therapy 43 black cohosh 43 Dr. Wassertheil Smoller 43 EMPHASIS HF trial 43 randomized Phase IIb 43 ARBITER 6 43 lasofoxifene 43 estradiol 43 BRIM3 43 RPGEH 43 postmenopausal hormone replacement 43 myocardial infarction MI 43 menopause symptoms 42 ENDEAVOR 42 EURIDIS 42 multicenter randomized 42 AROMASIN 42 lumbar spine BMD 42 CUSTOM II 42 magnesium intake 42 HealthCore 42 DES implantation 42 Study HERS 42 cosmetic breast implants 42 CAVEATS 42 Phase 2b study 42 ximelagatran 42 Sackner Bernstein 42 CYPHER ® Stent 42 COREG 42 calcium intake 42 metaanalysis 42 ADMIRE HF 42 selective COX 2 42 KIF6 gene variant 42 BRCA testing 42 oral deforolimus 42 undergone radical prostatectomy 42 Edward Giovannucci 42 arterial thromboembolic events 42 Raloxifene 42 anovulatory infertility 42 nonrandomized studies 42 Chodick 42 HCV SPRINT 42 Ovarian PLCO Cancer 42 Exemestane 42 National Surgical Adjuvant 42 randomized blinded 42 Phase Ia 42 Evaluation WISE 42 ROCKET AF 42 Phase Ib II 42 estrogen progestin hormone 42 retrospective cohort 42 adjuvant endocrine therapy 42 d4T 42 BOLDER II 42 postmenopausal osteoporotic women 42 oral ibandronate 42 Winkelmayer 42 GnRH agonists 42 intensive statin therapy 42 atorvastatin Lipitor 42 multivitamin supplements 42 TRA 2P 42 Stenting Trial CREST 42 varenicline 42 randomisation 42 Dr. Kandzari 42 RTOG 42 BZA CE 42 mg dose 42 BMD measurements 42 MEVACOR 42 HAART regimens 42 AVADO 42 hip BMD 42 Hilakivi Clarke 42 antioxidant supplementation 42 ziprasidone 42 SSRIs 42 Heart Failure Trial 42 SpHb monitoring 42 CaPSURE 42 enzastaurin 42 randomized double 42 vertebral fractures 42 fondaparinux 42 Fracture Intervention Trial 42 multicentre 42 lumiracoxib 42 journal Anesthesiology 42 ARCOXIA 42 prospectively defined 42 preterm birth 42 APTIVUS 42 morphometric vertebral fractures 42 cilostazol 42 acrylamide intake 42 PRIMO CABG2 42 intravenous bisphosphonates 42 liver transplant recipients 42 homocysteine concentrations 42 KIF6 carriers 42 idraparinux 42 nulliparous women 42 HIV seronegative 42 oxycodone CR 42 DHEA supplementation 42 hormonal contraceptives 42 NSAIDs 42 breast cancer recurrence 42 CVD mortality 42 multivariable analysis 42 antiplatelet therapy 42 Phase IIB 42 multicenter randomized clinical 42 pertuzumab 42 hormonal contraception 42 CYPHER R Stent 42 COURAGE 42 Randomized controlled 42 glargine 42 postoperative radiotherapy 42 JAMA 42 antihypertensive therapy 42 soy isoflavone 42 folic acid supplement 42 placebo 42 peginterferon 42 UKPDS 42 cerivastatin 42 STEP BD 42 containing drospirenone 42 Edge STudy 42 insulin glargine 42 folic acid 41 oral contraceptive pills 41 chromium supplementation 41 multicentre prospective 41 CLARITY TIMI 41 prospective observational studies 41 CALGB # [001] 41 folate deficiency 41 journal Menopause 41 Bresalier 41 Dose escalation 41 glatiramer acetate 41 Nutrition EPIC 41 hormones estrogen 41 cardioprotective effects 41 EMPHASIS HF 41 randomized crossover 41 treat menopausal symptoms 41 Trial NLST 41 olaparib 41 Celecoxib 41 Judith Hochman 41 LUX Lung 41 Rosuvastatin 41 cardiovascular 41 Marcia Stefanick 41 NCT# ClinicalTrials.gov 41 NRTI 41 DHA supplements 41 Normative Aging Study 41 Intrinsa 41 SYNTAX trial 41 neoadjuvant chemotherapy 41 LNG IUS 41 prostate carcinogenesis 41 bevacizumab 41 ACTOS 41 Natural S equol 41 cardiovascular disease 41 anticoagulation 41 dietary acrylamide 41 polypill 41 ASCEND HF 41 goserelin 41 REACH Registry 41 APPRAISE 41 PCOS 41 adjuvant therapy 41 oral contraceptive pill 41 Communities ARIC study 41 orofacial clefts 41 prespecified 41 Spine Patient Outcomes 41 ENGAGE AF TIMI 41 Bairey Merz 41 glycemic diet 41 reboxetine 41 preoperative chemotherapy 41 PLOS 41 adenoma recurrence 41 TAXUS stent 41 neoadjuvant treatment 41 postmenopausal hormone 41 serum GGT 41 osteoporotic fractures 41 hormonal therapy 41 Phase III VISTA 41 statin medications 41 Intergroup Exemestane Study 41 cardiovascular disease CVD 41 Communities ARIC Study 41 Progestin 41 dietary supplementation 41 mammography 41 EBRT 41 CYPHER Stent 41 antiepileptic drug 41 Dr. Henschke 41 HCV RESPOND 2 41 TURNS Treatment 41 antihypertensive drugs 41 statins cholesterol lowering 41 active comparator 41 endometrial hyperplasia 41 Clinical Endocrinology 41 journal Preventive Medicine 41 placebo controlled clinical trials 41 lamotrigine 41 CALERIE study 41 fat diets 41 journal Circulation Cardiovascular 41 tipranavir 41 myocardial infarctions MIs 41 LEXIVA r 41 IMPROVE HF 41 CALERIE 41 multivariate Cox 41 APTIVUS r 41 RIO Diabetes 41 LCP AtorFen 41 Phase III metastatic melanoma 41 antioxidant vitamin supplements 41 CHD 41 PFO closure 41 degarelix 41 strontium ranelate 41 Phase 2a trial 41 clinical trials 41 EDEMA3 41 PROSTVAC TM 41 SYNTAX 41 serum vitamin D 41 dietary antioxidants 41 cholesterol lowering drugs 41 medroxyprogesterone acetate 41 recurrent VTE 41 donepezil 41 Betaferon ® 41 undergoing coronary angiography 41 endometrial cancer 41 preterm delivery 41 metreleptin 41 antiretroviral therapy 41 #mg dosing group 41 clopidogrel 41 TAXUS ATLAS 41 REGARDS 41 GP IIb IIIa inhibitor 41 VTE 41 bazedoxifene 41 PFO migraine 41 olanzapine 41 prospective randomized placebo 41 prospective randomized multicenter 41 elevated CRP 41 L arginine 41 Mylotarg 41 coinvestigators 41 journal Stroke 41 Young Adults CARDIA 41 TYKERB 41 plasma folate 41 aromatase inhibitor 41 NCCTG N# 41 randomized multicentre 41 Subgroup analysis 41 knee osteoarthritis 41 recurrent venous thromboembolism 41 muraglitazar 41 NHANES III 41 lowering homocysteine 41 ASSERT 41 contralateral breast cancer 41 BOLDER 41 SIMPADICO 41 sulphonylureas 41 KLRI 41 dronedarone 41 EDARBI 41 NCCTG 41 estrogen progestin pill 41 hydroxychloroquine 41 vitamin B# supplements 41 pegylated interferon alfa 2b 41 undergoing CABG 41 VIRAMUNE 41 Stop Hypertension DASH 41 raltegravir 41 Celebrex 41 aripiprazole 41 progestin therapy 41 Unstable Angina 41 pharmacogenetic testing 41 meta regression 41 undergone hysterectomy 41 ABC/3TC 41 familial AF 41 elevated LDL cholesterol 41 NSAID 41 BENICAR HCT 41 placebo controlled Phase 41 HMG CoA reductase inhibitors 41 HIV seroconversion 41 #mg dose [003] 41 borderline statistical significance 41 paclitaxel eluting stents 40 venous thromboembolism 40 Reynolds Risk Score 40 paricalcitol 40 double blinded placebo 40 ginkgo biloba extract 40 thalidomide 40 journal Lancet Neurology 40 Radiology Imaging Network 40 Multiethnic Study 40 Avandia rosiglitazone 40 atypical hyperplasia 40 nonvertebral fracture 40 Tea Advisory Panel 40 coxibs 40 multicenter Phase 40 Renal Cell Carcinoma RCC 40 elagolix 40 Observational studies 40 dose escalation 40 LYSTEDA 40 irbesartan 40 randomized multicenter 40 SABCS 40 relieve menopausal symptoms 40 ticlopidine 40 Bowel Project NSABP 40 sildenafil Viagra 40 Prempro combination 40 carotid IMT 40 thrombotic events 40 SPIRIT FIRST 40 senicapoc 40 atorvastatin 40 tiotropium 40 ivabradine 40 phosphate binders 40 Candesartan 40 Arimidex 40 Polyp Prevention Trial 40 clinical pharmacology studies 40 Robert Califf 40 methodological limitations 40 Bowel Project 40 LV dysfunction 40 Stroke Prevention 40 norethindrone 40 CLBP 40 cholesterol lowering medication 40 NEVO 40 octreotide LAR 40 microbicide trials 40 pravastatin 40 liraglutide 40 thromboembolic 40 eplerenone 40 Thorough QT TQT 40 ARIMIDEX 40 aspirin therapy 40 TAXUS ARRIVE 40 prospective observational 40 phase IIa clinical 40 cerebral microbleeds 40 SLN biopsy 40 modifiable risk 40 PROTECT AF 40 Clinical Nutrition 40 abnormal glucose tolerance 40 fasting serum 40 lignan intake 40 number NCT# ClinicalTrials.gov 40 multicenter Phase II 40 Thorough QT 40 Complications Trial 40 landmark ATHENA 40 Acute Coronary Syndromes ACS 40 fibrates 40 journal Transfusion 40 postmenopausal estrogen 40 ZD# [001] 40 mild gestational diabetes 40 Xinlay 40 androgen deprivation 40 aflibercept 40 severe menopausal symptoms 40 placebo controlled randomized 40 Gynecological Cancer 40 PrEP 40 dosing cohorts 40 fluvastatin 40 PROVE IT 40 SHBG levels 40 GRAVITAS trial 40 citalopram Celexa 40 Histalean 40 arzoxifene 40 Protelos 40 skin sterol 40 randomized discontinuation trial 40 CHARISMA trial 40 Nalini Ranjit 40 phase IIb 40 gallstone disease 40 Dr. Montori 40 entecavir 40 perinatal outcomes 40 abiraterone 40 mycophenolate mofetil 40 colorectal adenoma 40 VIRAMUNE XR 40 Framingham Heart 40 desvenlafaxine succinate 40 antiretroviral naïve 40 Framingham Offspring 40 ALCL 40 vitamin D intakes 40 Crestor rosuvastatin 40 phytoestrogen intake 40 hip fractures 40 perimenopausal women 40 MDRD equation 40 Lp PLA2 40 BJU International 40 liver toxicity 40 vertebral fracture 40 pivotal bioequivalence 40 antiepileptic drugs 40 Calcium intake 40 minocycline 40 ischemic stroke 40 LPV r 40 zoledronic acid Zometa 40 celecoxib Celebrex 40 vegetable intake 40 duloxetine 40 adalimumab 40 Ophena 40 secondary efficacy endpoints 40 Hydroxyurea 40 postmarketing surveillance 40 JAMA. 40 Zevalin consolidation 40 bisphosphonate drugs 40 Baltimore Longitudinal Study 40 correlational 40 ADVANCE PD 40 adjuvant tamoxifen 40 MGd 40 prasugrel Effient 40 tolvaptan 40 cediranib 40 Patricia Hartge 40 TIMI Study Group 40 methotrexate therapy 40 advanced adenoma 40 androgen deficiency 40 bone mineral 40 abacavir 40 Interphone 40 randomized controlled trials RCTs 40 randomized multicenter Phase III 40 patients undergoing CABG 40 Endovascular Valve Edge 40 CATIE AD 40 UPLIFT 40 dietary modification 40 Reclast 40 ADAGIO study 40 prucalopride 40 CRESTOR #mg 40 Professionals Follow 40 rimonabant #mg 40 peg interferon 40 β blockers 40 Longitudinal Study 40 Cardiovascular Risk 40 Kivipelto 40 Observational Study 40 bezafibrate 40 Diabetes ACCORD 40 fenofibrate 40 GISSI HF 40 prospectively 40 PERSEUS 40 tumor histology 40 perimenopausal 40 PPIs 40 anacetrapib 40 dietary folate intake 40 CCCEH 40 randomizing patients 40 Estradiol 40 pCR 40 Menopause Society 40 drospirenone containing 40 COX 2s 40 residual confounding 40 pharmacologic treatments 40 Myocardial Infarction 40 rFVIIa 40 PCI ExTRACT TIMI 40 Anticoagulation 40 subclinical atherosclerosis 40 recurrent GBM 40 EVISTA 40 lacosamide 40 dabigatran etexilate 40 menopausal hormone 40 angiotensin receptor blockers 39 statin Crestor 39 Preventive Services 39 ICDs implanted 39 Trial ASCOT 39 everolimus eluting stents 39 Boston SmartAboutHealth 39 Alendronate 39 bolus dose 39 multivitamins 39 folic acid intake 39 longitudinal cohort study 39 fragility fractures 39 BioNumerik 39 quetiapine 39 rhGH 39 Natazia 39 Epidemiologic studies 39 Fonarow 39 prospectively stratified 39 AHRQ 39 NIH 39 anti TNF 39 vitamin D supplement 39 vitamin D inadequacy 39 telomere lengths 39 attain statistical significance 39 journal Urology 39 antithrombotic 39 C#G 39 systolic hypertension 39 Study AREDS 39 plus progestin hormone 39 PROCRIT therapy 39 spironolactone 39 SE5 OH containing 39 Simin Nikbin Meydani 39 loop diuretics 39 ranolazine 39 chromium picolinate 39 journal Hepatology 39 atypical antipsychotic medications 39 brain shrinkage 39 riociguat 39 thromboprophylaxis 39 longitudinal observational study 39 Teriflunomide 39 OLYMPIA registry 39 neoadjuvant 39 Perforomist Inhalation Solution 39 Radiation Therapy Oncology